Contraception

Papers
(The median citation count of Contraception is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Author response to ethinyl estradiol and levonorgestrel Phase 3 data clarification75
Copyright info/Contents56
Addendum to “Efficacy of oral levonorgestrel emergency contraception with same day etonogestrel contraceptive implant: A prospective observational study” [Contraception 131 (2024) 110344]51
“IT DEPENDS ON THE PERSON AND…ON THE SITUATION TOO”: FACTORS INFLUENCING ABORTION METHOD PREFERENCES AMONG BLACK AND LATINX COMMUNITIES IN THE US SOUTHEAST43
CHANGES IN BELIEFS ABOUT ABORTION SAFETY IN A NATIONALLY REPRESENTATIVE SAMPLE BETWEEN 2022 AND 202342
Editorial Board40
PHARMACIST ATTITUDES TOWARDS ADMINISTRATION OF DEPOT-MEDROXYPROGESTERONE ACETATE FOR CONTRACEPTION IN THE OUTPATIENT SETTING39
THE INTERSECTION OF ENGLISH PROFICIENCY AND NATIVITY IN RECEIPT OF PERSON-CENTERED CONTRACEPTIVE COUNSELING36
ASSOCIATION OF EXPANDED MEDICAID COVERAGE TO 12 MONTHS POSTPARTUM WITH CONTRACEPTIVE USE IN SOUTH CAROLINA35
ABORTION CARE PREFERENCES AND TRADE-OFFS WHEN TRAVELING OUT OF STATE FOR FACILITY-BASED SERVICES35
When doctors are “doxxed:” An analysis of information posted on an antiabortion website34
Over-the-counter oral contraception in the United States: An important opportunity at a time of increased concern about contraceptive access27
Perceptions of Legality and Availability of Abortion Care in Mississippi26
Copyright info/Contents26
Abortion research that matters: Using core outcomes to enable systematic review25
Society of Family Planning Annual Meeting 202224
P025Mail-order pharmacy dispensing of mifepristone for medication abortion after in-person clinical assessment24
O20Trauma responsive abortion care (on trac study): The abortion experiences of patients with a history of trauma24
P010Healthcare at the margins: The role of healthcare providers in self-managed abortion near the us-mexico border23
Copyright info/Contents22
Etonogestrel contraceptive implant uptake and safety among solid organ transplant recipients22
P081And then what happened? Assessing contraceptive use outcomes over three years among participants in the her salt lake contraceptive initiative22
Prescription opioid fills following surgical abortion21
Use of a contraceptive decision support tool in the abortion care setting21
Fetal tissue donation for research at the time of abortion: A qualitative study of individuals who experienced an abortion in Hawaii in 2018-1921
Complex family planning and pediatric hematology oncology integrated clinic for young people with blood disorders and heavy or abnormal menstrual bleeding21
Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens21
A pilot quasi-experimental controlled trial of a community-based, multilevel family planning intervention for couples in rural Uganda: evidence of feasibility, acceptability, and effect on contracepti20
Development of a Spanish-language drug facts label prototype for a combination mifepristone and misoprostol medication abortion product20
Editorial Board19
Expulsion rates of the levonorgestrel 52 mg intrauterine system are similar among women with heavy menstrual bleeding and users for contraception19
Association of body mass index on time to fetal expulsion for individuals undergoing medication abortion over 13 weeks gestational duration19
The role of advanced training in family planning and reproductive health in a low-income country; the experience of Ethiopia18
Money and place: Quantifying the types of obstacles associated with seeking an abortion after 10 weeks’ gestation, 2019–202018
From training to implementation: Improving contraceptive practices in South Carolina18
Medical contraindications to combined hormonal contraceptive use among women using methods prescribed by a pharmacist18
Evaluating the Quality and Communicative Aspects of Contraceptive Decision Aids18
GeneFlex—A Chinese generic intrauterine device not to be confused with GyneFix17
Effect of neighborhood-level income on access to emergency contraception17
Integrating anti-violence efforts into sexual and reproductive health: Reproductive coercion as a case example17
Fetomaternal hemorrhage assessment in Rh-negative patients undergoing dilation and evacuation between 20 and 24 weeks’ gestational age: A retrospective cohort study17
Society of Family Planning Committee Statement: Contraceptive considerations for individuals with cancer and cancer survivors part 1 – Key considerations for clinical care Joint with the Society of Gy16
“So that I can trust them with my body:” How people with low incomes who may become pregnant define and prioritize quality reproductive health care16
PREDICTORS OF ABORTION PROVISION AMONG OBSTETRICIAN-GYNECOLOGISTS IN MASSACHUSETTS16
POSTER ABSTRACTS16
Vomiting and risk of endotracheal intubation related to preoperative doxycycline use for dilation and evacuation16
Social and provider networks and women's contraceptive use: Evidence from Madagascar15
Pharmacist provision of medication abortion: A pilot study15
Society of Family Planning Clinical Recommendation: Prevention of infection after abortion and pregnancy loss15
Evaluation of ovulation and safety outcomes in a multi-center randomized trial of three 84 day ulipristal acetate regimens15
P091Impact of adverse childhood experiences, anxiety, and resilience on pain during office manual uterine aspiration14
Immediate postpartum contraceptive implant placement and breastfeeding success in postpartum people at risk for low milk supply: A randomized non-inferiority trial14
MOTIVATIONS TO INITIATE AND CONTINUE CONTRACEPTIVE USE AMONG SEXUAL MINORITY YOUNG WOMEN IN THE SOUTHEASTERN US14
Management of cesarean scar ectopic pregnancies at an academic referral center: A case series14
P038Ketamine versus fentanyl for surgical abortions: A randomized noninferiority trial14
POSTER ABSTRACTS14
O18Trends in copper versus hormonal intrauterine device breakage reporting within the us food and drug administration adverse event reporting system14
Changes in contraceptive use during the second COVID-19 lockdown in Brazil: A web-based survey14
NEIGHBORHOOD-LEVEL RACIALIZED SOCIOECONOMIC DEPRIVATION AND CONTRACEPTIVE USE IN THE US, 2011–201914
Copyright info/Contents13
Classification of periviable pregnancy-ending interventions for maternal life endangerment as induced abortion13
“AY, CÁLLATE, GROSERA. NO DIGAS ESO”: LEARNING ABOUT SEXUALITY AMONG MIDDLE TO OLDER AGE LATINAS IN THE PACIFIC NORTHWEST13
POST-PLACENTAL LNG-IUD OUTCOMES AT A LARGE COUNTY HOSPITAL IN TEXAS13
Contraceptive care experiences and preferences among Black women in Mississippi: A qualitative study12
Health care access and contraceptive use among adult women in the United States in 201712
Delivery of home-based postpartum contraception in Southwest Trifinio, Guatemala: Reach, adoption, and implementation in a cluster-randomized trial12
HAVE WE EXPANDED ACCESS? THE IMPACT OF ABORTION TELEHEALTH IN A STATE WITH EXTENSIVE REPRODUCTIVE HEALTH DESERTS12
Unintended pregnancy among U.S. military active duty servicemembers: Estimates for 2018 and trends since 200512
Emergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel12
Safety testing of Ovaprene: An investigational nonhormonal monthly vaginal contraceptive12
Telehealth contraceptive care in 2018: A quality improvement study of barriers to access and patient satisfaction12
A novel approach to cervical dilation for second-trimester dilation and evacuation in a myomatous uterus12
Health-related quality of life and satisfaction associated with 3-year use of a levonorgestrel 13.5 mg intrauterine device vs Nova T copper 380 mm2 intrauterine device: Results of a phase 4 randomized12
POSTER ABSTRACTS11
Ohio survey data assessing perceptions of abortion safety11
FUNCTIONAL RECOVERY AFTER SURGICAL UTERINE EVACUATION11
O19Experiences of racial/ethnic discrimination and contraceptive use: A longitudinal study11
Patient-reported experience with discussion of all options during pregnancy options counseling in the US South11
POSTER ABSTRACTS11
PERINATAL NURSING BEREAVEMENT WORKSHOP - TRAINING FOR CRITICAL PERINATAL PATIENTS11
POSTER ABSTRACTS11
Postpartum long-acting reversible contraception among privately insured: U.S. National analysis 2007–2016, by term and preterm birth11
Contraceptive provision in Oregon school-based health centers: Method type trends and the role of Title X11
Maternal complications associated with second trimester medical abortion using mifepristone priming and subsequent misoprostol11
Editorial Board11
Retraction notice to "An integrated analysis of nonmenstrual adverse events with Implanon" [Contraception 58 (1998) S109-S115]10
Expulsion of a fragmented laminaria one week after a same-day dilation and evacuation procedure10
TEMPORARILY WITHDRAWN: Does the shape of the copper intrauterine device play a role in expulsion? Results from the ongoing European Active Surveillance Study on LCS1210
How did regional lockdowns during the COVID-19 pandemic affect recruitment into a large multinational cohort study of intrauterine device users?10
Suspected hepatotoxicity from etonogestrel contraceptive implant: A rare case report10
P084The role of pediatric subspecialists in adolescent and young adult contraceptive care10
A statewide analysis of uptake of highly effective contraception offered immediately postpartum in Massachusetts, 2017–202110
Management of early pregnancy loss among obstetrician-gynecologists in Massachusetts and barriers to mifepristone use10
An exploratory examination of attitudes toward illegal abortion in the U.S. through endorsement of various punishments10
P019Illinois patient experiences with public and private insurance coverage for abortion following policy change10
Patient opinions on sexual and reproductive health services in primary care in rural and urban clinics10
DISTANCE TRAVELED TO OBTAIN ABORTION CARE IN SOUTHERN ILLINOIS BEFORE AND AFTER THE DOBBS V JACKSON WOMEN’S HEALTH ORGANIZATION DECISION10
Individual, partner, and community variables associated with method-specific contraceptive beliefs in urban and rural Kenya10
“The right thing to do would be to provide care… and we can’t”: Provider experiences with Georgia’s 22-week abortion ban9
POSTER ABSTRACTS9
Editorial Board9
EXAMINING “BELIEFS” ABOUT ABORTION--WHAT IS ABORTION AND HOW SHOULD ABORTION BE REGULATED: FINDINGS FROM A MULTI-STATE CROSS-SECTIONAL SURVEY.9
Society of Family Planning Clinical Recommendation: Management of hemorrhage at the time of abortion9
Patient-controlled intravenous versus on-demand oral, intramuscular or mcs intravenous administration of oxycodone during medical induced abortion from 64 to 128 days of Gestation: A randomized contro9
POSTER ABSTRACTS9
“THAT’S A TRICKY ONE”: ACCESS TO MISOPROSTOL FOR EARLY PREGNANCY LOSS IN RETAIL PHARMACIES ACROSS ARIZONA9
P007Accuracy of self-assessment of pregnancy duration eligibility for medication abortion among young people: The advantages of expanding screening questions beyond date of last menstrual period9
Contraception and nonalcoholic fatty liver disease in women with prior gestational diabetes mellitus9
Adherence among a cohort taking progestin-only pills prescribed by a healthcare provider: Results of the BENCHMARK study9
Caregivers of youth in foster care in Texas and their role in contraception decision-making for adolescents in care9
EXPERIENCES OF COST-RELATED DELAYS ACCESSING ABORTION CARE AND PRE-ABORTION PSYCHOLOGICAL WELL-BEING9
Retraction notice to “Introduction: Presentation of clinical data on implanon®1” [Contraception 58 (1998) S75−S77]8
Beyond pain medication: striving toward more patient-centered placement of intrauterine devices8
P030Interest in rh testing and rho(d) immune globulin received among patients obtaining first-trimester medication abortion through virtual clinics8
ABORTION TRENDS AT A SINGLE CLINIC IN SOUTHERN ILLINOIS BEFORE AND AFTER THE DOBBS V. JACKSON WOMEN’S HEALTH ORGANIZATION DECISION8
Decomposition analysis of racial and ethnic differences in receipt of immediate postpartum, long-acting, reversible, and permanent contraception8
Variation in the interpretation and application of the Medicaid sterilization consent form among Medicaid officials8
Trajectories of method dissatisfaction among Kenyan women using modern, reversible contraception: A prospective cohort study8
Pharmacy deserts: A complexity that worsens contraception access in the United States8
Beyond stigma: Clinician bias in contraceptive counseling to sexual and gender minority youth8
ABORTION PATIENTS’ AWARENESS AND UNDERSTANDING OF AN EARLY PREGNANCY ABORTION BAN AND ACCESS TO IN-STATE CARE8
An intersectional analysis of contraceptive types chosen among sexual minority women: A nationally representative study8
Pelvic examination under anesthesia by learners at the time of abortion: Who accepts and who declines?8
Where do female contraceptive users get their methods, and does this differ by insurance coverage? A state-level examination8
Design of an international male contraceptive efficacy trial using a self-administered daily transdermal gel containing testosterone and segesterone acetate (Nestorone)8
Understanding medication abortion ineligibility due to gestational age among a cohort of patients in Southern California8
EVALUATION OF A VIRTUAL “NO TOUCH” ABORTION PROGRAM IMPLEMENTED IN THE GREATER TORONTO AREA DURING THE COVID-19 PANDEMIC8
ASSESSING THE IMPACT OF HEALTH EQUITY-INFORMED QUALITY IMPROVEMENT ON CONTRACEPTIVE CARE SCREENING, COUNSELING, AND PROVISION8
Sampling strategies among studies of barriers to abortion in the United States: A scoping review of abortion access research8
Drug-drug interactions between antiretrovirals and hormonal contraception: An updated systematic review8
RISK FACTORS FOR SHORT-INTERVAL BIRTHS POST IPP LARC PLACEMENT IN TENNESSEE8
Racial and Ethnic Differences in Risk for Hysterectomy Following Insertion of a Levonorgestrel-releasing Intra-uterine device: A Retrospective Cohort Study7
URGENT, EMERGENT, OR JUST MISSED? GEOPOLITICAL VARIATIONS IN THE MANAGEMENT OF EARLY PREGNANCY LOSS IN US EMERGENCY DEPARTMENTS7
P022Growing national interest and support for advance provision and over-the-counter access to medication abortion7
Corrigendum to “Participation in an HIV prevention intervention and access to and use of contraceptives among young women: A cross-sectional analysis in six South African districts” [Contraception 1167
Effectiveness and safety of medication abortion via telemedicine versus in-person: A cohort of pregnant people in Colombia7
WHY US MEN HAVE ABORTIONS: QUANTITATIVE AND QUALITATIVE PERSPECTIVES FROM URBAN FAMILY PLANNING CLINICS7
POSTER ABSTRACTS7
PATIENT PERSPECTIVES ON OUT-OF-STATE TRAVEL FOR ABORTION CARE POST-DOBBS7
CREATING A TIME-SENSITIVE DATABASE TO MEASURE STATE-LEVEL OUTPATIENT CONTRACEPTION UTILIZATION IN MEDICAID7
CONCURRENT ADMINISTRATION OF DEPOT MEDROXYPROGESTERONE ACETATE WITH MIFEPRISTONE MAY DECREASE MEDICATION ABORTION EFFICACY: A RETROSPECTIVE COHORT STUDY7
Understanding the mechanical behavior of intrauterine devices during simulated removal7
Effectiveness, safety, and acceptability of postplacental insertion of GyneFix postpartum intrauterine device among women undergoing cesarean section: A multicenter prospective cohort study in China7
EFFICACY AND SAFETY OF THE ESTETROL/DROSPIRENONE ORAL CONTRACEPTIVE IN US STUDY PARTICIPANTS WITH AND WITHOUT OBESITY7
Racial and ethnic disparities in short interval pregnancy following delivery in Catholic vs non-Catholic hospitals among California Medicaid enrollees7
Assessment of adolescent decision-making capacity for pharmacy access to hormonal contraception7
PREGNANCY OPTIONS CONSIDERED AMONG NEWLY PREGNANT PEOPLE IN THE SOUTHWEST US7
The association between state-level abortion restrictions and maternal mortality in the United States, 1995-20177
Remote Provision and Self-Administration of Misoprostol as Cervical Preparation for Hospital-Based Uterine Evacuation Between 14-18 Weeks6
P064Depression after 12-month use of oral or intrauterine contraception6
ASSESSING QUALITY OF CONTRACEPTIVE COUNSELING AT A POPULATION LEVEL: AN OPPORTUNITY TO INFORM EQUITABLE CARE DELIVERY6
REPORTED ABORTION TRAINING OPPORTUNITIES AMONG TEXAS PGY-1 OB-GYN RESIDENTS AFTER THE FALL OF ROE6
Expert participation in 25 years of Wisconsin abortion policymaking6
WHAT INFORMATION DO PEOPLE NEED TO SUPPORT SELF-MANAGED GENDER AFFIRMING HORMONE THERAPY (GAHT) IN THE US? A QUALITATIVE EXPLORATION OF REDDIT POSTS6
Procedural abortion in individuals with opioid dependence: Patient characteristics and pain experience6
“That is when I understood everything”: Ideological trajectories of pro-choice female doctors in Mexico6
Factors associated with postpartum contraceptive planning in New Zealand6
Male contraception – Part of gender medicine and reproductive rights of men6
IMPROVING ESTIMATES OF MEDICATION ABORTION EFFECTIVENESS: THE IMPACT OF LOSS TO FOLLOW-UP6
P056Oral contraceptive adherence and pregnancy rates in estetrol/drospirenone pooled phase 3 trials6
“I’M NOT SOMEONE WHO WOULD EVER HAVE AN ABORTION”: MANAGING ABORTION STIGMA AFTER DIAGNOSIS OF A SEVERELY MORBID OR LETHAL FETAL CONDITION6
Telemedicine for medical abortion service provision in Mexico: A safety, feasibility, and acceptability study6
In reply to LTE: “Weighing risks and centering patients within clinical guidelines”6
PUBLIC SUPPORT FOR REPORTING AND PUNISHING PEOPLE WHO USE ALCOHOL OR DRUGS WHILE PREGNANT6
Disparities in Perceptions of Long-Acting Reversible Contraceptives among Patients in Delaware Title X Clinics6
Testing the validity and reliability of the Person-Centered Contraceptive Counseling (PCCC) Performance Measure in a Real-World Contraceptive Access Program6
Use of PROMIS Global-10 to measure changes in health-related quality of life among contraceptive initiators; a feasibility study6
Featured research at the 2023 Society of Family Planning Annual Meeting6
Impact of new abortion restrictions on people in prison: Estimated number of incarcerated people without abortion access and distance to abortion providers6
ONGOING CONTRACEPTIVE GOALS FOR PATIENTS WHO DO NOT ACHIEVE DESIRED POSTPARTUM PERMANENT CONTRACEPTION PRIOR TO HOSPITAL DISCHARGE6
P068Navigating uncertainty: (In)fertility and reproductive planning6
ESTIMATING EMERGENCY CONTRACEPTION EFFICACY WITH LEVONORGESTREL AND COPPER INTRAUTERINE DEVICES6
Ally, the pioneering abortion chatbot: Capturing regional variations in self-managed abortion needs6
Factors associated with a negative Patient Acceptable Symptom State (PASS) response with intrauterine device placement: A retrospective survey of HER Salt Lake participants6
EXPLORING THE IMPACTS OF DOBBS DECISION ON ABORTION TRAINING AT RYAN PROGRAMS6
ORAL ABSTRACTS5
POSTER ABSTRACTS5
Providing family planning counseling services for women with chronic medical conditions in an inpatient setting: A randomized feasibility trial5
Patient Acceptability of Asynchronous vs Synchronous Telehealth Abortion Care: A Cohort Study of Telehealth Abortion Care Provided by Virtual Clinics in the United States5
Estetrol/Drospirenone safety in a population with cardiovascular risk factors5
Catholic sole community hospitals are associated with decreased receipt of postpartum permanent contraception among Medicaid recipients5
Accessibility of oral emergency contraceptives in Australian community pharmacies5
Clinical interventions are more accurate than quantitative measurements for defining hemorrhage with dilation and evacuation5
O17Immediate postpartum contraceptive implant placement and breastfeeding success in women at risk for low milk supply: A randomized non-inferiority trial5
Association of willingness to use hormonal contraception with knowledge: A national survey5
Copyright info/Contents5
Exploring the experience of IUD self-removal in the United States through posts on internet forums5
Modeling the potential benefit of an over-the-counter progestin-only pill in preventing unintended pregnancies in the U.S.5
POSTER ABSTRACTS5
LEVONORGESTREL 52 MG INTRAUTERINE DEVICE PLACEMENT WITHOUT SOUNDING: A FEASIBILITY STUDY5
Intrauterine device self-removal practices during the COVID-19 pandemic among family planning clinics5
POSTER ABSTRACTS5
Management of heterotopic pregnancy with uterine aspiration and systemic two-dose methotrexate5
Provider perspectives on patient-centered contraceptive counseling for Latinas in Baltimore, MD5
The experience of pain in real-time during medication abortion5
The effects of offering immediate postpartum placement of IUDs and implants to pregnant patients with heart disease5
Abortion at 12 or more weeks’ gestation and travel for later abortion care among Mississippi residents5
Society of Family Planning Research Practice Support: Approaching the concepts of gender and sex in family planning research5
P090Perceptions of hiv risk screening strategies among patients seeking abortion, contraception, and pregnancy loss management5
P092Measuring utilization of mifepristone in medication management of missed abortions: Retrospective claims analysis study5
Editorial Board5
Healthcare provider communication and current contraceptive use among transgender men and gender-diverse people: Results from an online, cross-sectional survey in the United States5
Impact of the hands-on clinical training program for subdermic implant on contraceptive counseling and users' choice in Spain: A 6-month follow-up study5
POSTER ABSTRACTS5
ASSOCIATION BETWEEN EXPERIENCES OF DISCRIMINATION AND CONCERNS ABOUT ACCESSING CONTRACEPTIVE CARE AMONG COMMUNITY COLLEGE STUDENTS IN TEXAS AND CALIFORNIA5
Response to Dr. Winter's letter5
IMMEDIATE POSTPARTUM STERILIZATION AFTER VAGINAL DELIVERY IN THE PRE-COVID AND COVID PERIODS IN NEW YORK5
Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: A randomized proof-of-concept study5
Effectiveness and safety of a direct-to-patient telehealth service providing medication abortion targeted at rural and remote populations: Cross-sectional findings from Marie Stopes Australia5
Helping patients choose between pain control options for outpatient procedural abortion at less than 12 weeks' gestation5
One-year continuation of the etonogestrel contraceptive implant initiated with oral emergency contraception5
Editorial Board5
P079Etonogestrel contraceptive implant users can experience breakthrough ovulation with only two weeks of exposure to a strong cyp3a inducer5
The Voices of Doctors Who Provide Abortion Care Increase Public Support for Legal Abortion by Replacing Flawed Negative Stereotypes with Positive Images of Compassion, Skill and Conscience5
Copyright info/Contents5
Society of Family Planning clinical recommendations: Contraception and abortion care for persons who use substances5
Contraception information on the websites of student health centers in the United States5
ADAPTATION AND VALIDATION OF THE CONTRACEPTIVE AGENCY SCALE FOR THE US5
Copyright info/Contents4
ESTIMATED INCREASE IN SEVERE MATERNAL MORBIDITY DUE TO A TOTAL ABORTION BAN IN THE US4
Is it an abortion: Classification of pregnancy-ending interventions after 24 weeks in the presence of lethal fetal anomalies4
The association of patient age, race, and demographic features on reported pain and sedation dosing during procedural abortion: A retrospective cohort study4
A case report of eosinophilia associated with an etonogestrel implant4
Do miscarriage care practice recommendations align with individuals’ needs?: A scoping review4
Effectiveness and efficacy rates of progestin-only pills: A comprehensive literature review4
Refugee women's experiences with contraceptive care after resettlement in high-income countries: A critical interpretive synthesis4
“It’s different than a doctor saying ‘You’re making the right choice’”: A qualitative study of chaplains’ experience caring for patients undergoing abortion in Washington DC, Maryland, and Virginia4
Amenorrhea in adolescents using the etonogestrel contraceptive implant4
Copyright info/Contents4
O12Barriers to abortion access for young southerners: a qualitative analysis of case notes from arc-southeast4
Exploring the prevalence of abortion and its characteristics in Perú4
Comparing transcervical balloon with osmotic dilators for cervical preparation prior to procedural abortion: A noninferiority randomized trial4
Participation in an HIV prevention intervention and access to and use of contraceptives among young women: A cross sectional analysis in six South African districts4
Efficacy of a low-sensitivity urine pregnancy test for identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation4
Exploring primary care physician biases in adolescent contraceptive counseling4
PHARMACY PRESCRIBING IS ALLOWED; WHY ISN’T IT HAPPENING?4
Editorial Board4
POSTER ABSTRACTS4
P003“We are completely captured”: The influence of us foreign policy through the global gag rule on malawi's sexual and reproductive health and rights landscape4
Unanswered questions from abortion seekers: An application of the Research Prioritization by the Affected Community (RPAC) protocol in the Central Valley, California4
“I HAVE INSURANCE BUT I’M UNSURE IF I’M COVERED”: EVALUATING 13 MONTHS OF MESSAGES TO A YOUTH-FOCUSED, REPRODUCTIVE JUSTICE TEXT LINE IN MISSOURI4
Post-ablation tubal sterilization syndrome: Does route of sterilization matter?4
P083The impact of federal and state-level contraceptive coverage policies on contraceptive cost and use among privately insured women4
Economic evaluation of Zika Contraception Access Network in Puerto Rico during the 2016–17 Zika virus outbreak4
Effects of aromatherapy on patient satisfaction with procedural abortion at less than 10 weeks’ gestation: A randomized controlled trial4
An examination of loss to follow-up and potential bias in outcome ascertainment in a study of direct-to-patient telemedicine abortion in the United States4
CHANGE IN CLINIC VOLUME AND GESTATIONAL AGE AT TIME OF ABORTION IN SOUTHERN ILLINOIS BEFORE AND AFTER DOBBS V JACKSON WOMEN’S HEALTH ORGANIZATION4
The next two decades of mifepristone at FDA: History as destiny,4
POSTER ABSTRACTS4
Language-based acculturation is linked with reproductive autonomy among Oregon Mexican-origin Latinas4
0.035737991333008